How is Breast Cancer that has spread to the liver treated

Treatment of Breast Cancer That Has Spread to the Liver

When breast cancer spreads to the liver, it's called metastatic breast cancer or advanced breast cancer. This is still considered breast cancer—not liver cancer—because the cancer cells originated in the breast. Treatment depends on several factors specific to your situation.

How Doctors Approach This

According to the NCCN Guidelines for Patients: Metastatic Breast Cancer, your care team will first determine:

• How many liver tumors you have and their size
• Whether the tumors can be surgically removed (resectable vs. unresectable)
• Your hormone receptor status (ER/PR positive or negative)
• HER2 status (positive or negative)
• Other biomarkers that might respond to targeted therapies
• Your overall health and liver function

Main Treatment Approaches

1. Systemic Therapy (Chemotherapy, Hormone Therapy, or Targeted Therapy)

This is typically the first-line treatment for most patients with liver metastases. Systemic therapy means medications that travel through your bloodstream to reach cancer cells throughout your body:

• For hormone receptor-positive (HR+) breast cancer: Endocrine therapy (hormone-blocking medications) is often used, sometimes combined with targeted therapies
• For HER2-positive breast cancer: HER2-targeted therapies like trastuzumab (Herceptin) combined with chemotherapy
• For triple-negative breast cancer: Chemotherapy is the primary option
• Certain biomarkers like PIK3CA, ESR1, or NTRK mutations may respond to specific targeted drugs

2. Surgery (Hepatic Resection)

In carefully selected cases, surgical removal of liver metastases may be considered, particularly if:

• You have a small number of tumors
• The tumors are resectable (can be safely removed)
• You've responded well to initial systemic therapy
• Your liver function is adequate

According to NCCN guidelines, surgery is preferred over other local techniques when feasible, though this is typically done after systemic therapy has shown benefit.

3. Local Therapies

For patients who cannot have surgery or whose disease doesn't respond to systemic therapy, other options include:

• Thermal ablation (using heat to destroy tumors) - equivalent to surgery for small lesions (≤3 cm)
• Stereotactic body radiation therapy (SBRT) - focused radiation delivered in few high-dose treatments
• Arterially directed therapies - delivering chemotherapy or radiation directly to the liver through blood vessels

The Role of Biomarker Testing

Before starting treatment, your doctor will test your cancer for specific markers:

• Hormone receptors (estrogen and progesterone)
• HER2 status
• Tumor mutations (PIK3CA, ESR1, NTRK, RET, and others)
• BRCA1/2 status (germline testing is recommended for all metastatic breast cancer patients)

These results directly guide which treatments will be most effective for your specific cancer.

What This Means for Your Care

Treatment is highly individualized. Your oncologist will create a plan based on:

• Your cancer's specific characteristics
• How many metastases you have
• Your overall health and preferences
• How your cancer responds to initial treatment

Many patients receive a combination of systemic therapy with or without local therapies, depending on their situation.

Questions to Ask Your Oncologist

1. What is my cancer's hormone receptor status, HER2 status, and what biomarkers were found?
2. Are my liver metastases resectable, or is systemic therapy the best first approach?
3. Which systemic therapy do you recommend, and why is it best for my specific cancer?
4. How will we measure whether the treatment is working?
5. What are the potential side effects, and how will we manage them?
6. If my cancer doesn't respond to the first treatment, what are the next options?
7. Are there clinical trials available for my specific type of metastatic breast cancer?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.